No retraction, correction or concern found when last checked on Oct 30, 2026.
Parkinson's Disease and Systemic Inflammation
Carina C. Ferrari, Rodolfo Tarelli
Parkinson's Disease · 2011
Abstract
Peripheral inflammation triggers exacerbation in the central brain's ongoing damage in several neurodegenerative diseases. Systemic inflammatory stimulus induce a general response known as sickness behaviour, indicating that a peripheral stimulus can induce the synthesis of cytokines in the brain. In Parkinson's disease (PD), inflammation was mainly associated with microglia activation that can underlie the neurodegeneration of neurons in the substantia nigra (SN). Peripheral inflammation can transform the “primed” microglia into an “active” state, which can trigger stronger responses dealing with neurodegenerative processes. Numerous evidences show that systemic inflammatory processes exacerbate ongoing neurodegeneration in PD patient and animal models. Anti-inflammatory treatment in PD patients exerts a neuroprotective effect. In the present paper, we analyse the effect of peripheral infections in the etiology and progression in PD patients and animal models, suggesting that these peripheral immune challenges can exacerbate the symptoms in the disease.
Cited by papers we hold 8
- Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets · 2023No notice
- Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications · 2020No notice
- Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment · 2018No notice
- Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration · 2017No notice
- Decrease of gene expression of astrocytic 5-HT2B receptor parallels development of anhedonia in a mouse model of Parkinson’s disease · 2015Not checked
- The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders · 2015No notice
- Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses · 2015No notice
- The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys · 2011No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.